|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||||||||||||||
| Pledged assets | ||||||||||||||||||||
| Asset Pledged as Collateral | ||||||||||||||||||||
| Asset Not Pledged as Collateral | ||||||||||||||||||||
| Total pledged assets | ||||||||||||||||||||
| U.S. Treasury securities, at fair value | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Asset Pledged as Collateral | ||||||||||||||||||||
| Total restricted cash | ||||||||||||||||||||
| Orchid Island Capital, Inc. common stock, at fair value | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Asset Pledged as Collateral | ||||||||||||||||||||
| Total accrued interest receivable | ||||||||||||||||||||
| Identifiable intangibles, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total accounts receivable | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Asset Pledged as Collateral | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Repurchase agreements | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interest | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY: | ||||||||||||||||||||
| Preferred stock, $0.001 par value; 10,000,000 shares authorized; 100,000 shares designated Series A Junior Preferred Stock, 9,900,000 shares undesignated; no shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Common Class B | ||||||||||||||||||||
| Common Class C | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities, Redeemable Noncontrolling Interest and Stockholders' Equity | ||||||||||||||||||||
Loading...